| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyCellularComponent | ciliary membrane | 5.15e-05 | 98 | 140 | 6 | GO:0060170 | |
| Domain | EFh | 1.38e-04 | 158 | 133 | 7 | SM00054 | |
| Domain | EF_HAND_2 | 2.52e-04 | 231 | 133 | 8 | PS50222 | |
| Domain | EF_hand_dom | 2.60e-04 | 232 | 133 | 8 | IPR002048 | |
| Domain | EF-hand_7 | 3.53e-04 | 85 | 133 | 5 | PF13499 | |
| Domain | Stomatin_fam | 4.96e-04 | 5 | 133 | 2 | IPR001972 | |
| Domain | WD40 | 5.41e-04 | 259 | 133 | 8 | PF00400 | |
| Domain | - | 6.42e-04 | 333 | 133 | 9 | 2.130.10.10 | |
| Domain | WD40/YVTN_repeat-like_dom | 6.70e-04 | 335 | 133 | 9 | IPR015943 | |
| Domain | WD40 | 6.77e-04 | 268 | 133 | 8 | SM00320 | |
| Domain | WD40_repeat | 7.46e-04 | 272 | 133 | 8 | IPR001680 | |
| Domain | WD_REPEATS_1 | 8.59e-04 | 278 | 133 | 8 | PS00678 | |
| Domain | WD_REPEATS_2 | 8.79e-04 | 279 | 133 | 8 | PS50082 | |
| Domain | WD_REPEATS_REGION | 8.79e-04 | 279 | 133 | 8 | PS50294 | |
| Domain | EGF_extracell | 8.80e-04 | 60 | 133 | 4 | IPR013111 | |
| Domain | EGF_2 | 8.80e-04 | 60 | 133 | 4 | PF07974 | |
| Domain | SIX1_SD | 1.03e-03 | 7 | 133 | 2 | IPR031701 | |
| Domain | SIX1_SD | 1.03e-03 | 7 | 133 | 2 | PF16878 | |
| Domain | EF-hand-dom_pair | 1.05e-03 | 287 | 133 | 8 | IPR011992 | |
| Domain | WD40_repeat_dom | 1.31e-03 | 297 | 133 | 8 | IPR017986 | |
| Domain | DHC_N1 | 1.37e-03 | 8 | 133 | 2 | PF08385 | |
| Domain | Dynein_heavy_dom-1 | 1.37e-03 | 8 | 133 | 2 | IPR013594 | |
| Domain | EF_Hand_1_Ca_BS | 1.60e-03 | 175 | 133 | 6 | IPR018247 | |
| Domain | Ig_I-set | 2.42e-03 | 190 | 133 | 6 | IPR013098 | |
| Domain | I-set | 2.42e-03 | 190 | 133 | 6 | PF07679 | |
| Domain | Band_7 | 2.65e-03 | 11 | 133 | 2 | IPR001107 | |
| Domain | Band_7 | 2.65e-03 | 11 | 133 | 2 | PF01145 | |
| Domain | PHB | 2.65e-03 | 11 | 133 | 2 | SM00244 | |
| Domain | - | 2.68e-03 | 261 | 133 | 7 | 1.10.238.10 | |
| Domain | EF_HAND_1 | 3.43e-03 | 204 | 133 | 6 | PS00018 | |
| Domain | SSD | 3.73e-03 | 13 | 133 | 2 | IPR000731 | |
| Domain | SSD | 3.73e-03 | 13 | 133 | 2 | PS50156 | |
| Domain | Inhibin_asu | 3.73e-03 | 13 | 133 | 2 | IPR002405 | |
| Domain | Dynein_heavy_chain_D4_dom | 4.33e-03 | 14 | 133 | 2 | IPR024317 | |
| Domain | Dynein_HC_stalk | 4.33e-03 | 14 | 133 | 2 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 4.33e-03 | 14 | 133 | 2 | IPR013602 | |
| Domain | DHC_N2 | 4.33e-03 | 14 | 133 | 2 | PF08393 | |
| Domain | ATPase_dyneun-rel_AAA | 4.33e-03 | 14 | 133 | 2 | IPR011704 | |
| Domain | MT | 4.33e-03 | 14 | 133 | 2 | PF12777 | |
| Domain | AAA_8 | 4.33e-03 | 14 | 133 | 2 | PF12780 | |
| Domain | AAA_5 | 4.33e-03 | 14 | 133 | 2 | PF07728 | |
| Domain | SH3 | 4.53e-03 | 216 | 133 | 6 | PS50002 | |
| Domain | EF-hand_1 | 4.66e-03 | 152 | 133 | 5 | PF00036 | |
| Domain | SH3_domain | 4.95e-03 | 220 | 133 | 6 | IPR001452 | |
| Domain | DHC_fam | 4.97e-03 | 15 | 133 | 2 | IPR026983 | |
| Domain | Dynein_heavy | 4.97e-03 | 15 | 133 | 2 | PF03028 | |
| Domain | Dynein_heavy_dom | 4.97e-03 | 15 | 133 | 2 | IPR004273 | |
| Domain | fn3 | 6.09e-03 | 162 | 133 | 5 | PF00041 | |
| Domain | AMP-bd_C | 6.38e-03 | 17 | 133 | 2 | IPR025110 | |
| Domain | AMP-binding_C | 6.38e-03 | 17 | 133 | 2 | PF13193 | |
| Domain | IGc2 | 6.78e-03 | 235 | 133 | 6 | SM00408 | |
| Domain | Ig_sub2 | 6.78e-03 | 235 | 133 | 6 | IPR003598 | |
| Domain | - | 6.98e-03 | 106 | 133 | 4 | 1.10.150.50 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | L1CAM OBSCN TRMT11 MIB2 PTCH1 TEP1 ZZEF1 BIRC6 ITGB4 PLEKHH3 BMP8B THADA PWWP2B SCAP WIZ MAP1S RPTOR PKD1 HES6 SPATA13 | 2.65e-08 | 1105 | 142 | 20 | 35748872 |
| Pubmed | PITHD1 GPRASP1 DCAF6 LURAP1 ANK2 OBSL1 OAT KANK2 TRIP12 FAM53C DCAF5 RYR3 TXNDC15 WIZ MAP1S SACS PKD1 MAST1 MACF1 PLAUR MVP | 6.52e-08 | 1285 | 142 | 21 | 35914814 | |
| Pubmed | 5.89e-07 | 118 | 142 | 7 | 30979931 | ||
| Pubmed | 8.98e-07 | 43 | 142 | 5 | 36950384 | ||
| Pubmed | 1.32e-06 | 6 | 142 | 3 | 9878243 | ||
| Pubmed | 2.66e-06 | 24 | 142 | 4 | 17676665 | ||
| Pubmed | 3.15e-06 | 25 | 142 | 4 | 22479201 | ||
| Pubmed | DCAF6 ZNF219 OBSL1 TEP1 ZZEF1 KANK2 FAM53C DCAF5 THADA PWWP2B WIZ ZFHX4 RPTOR SMARCD1 MACF1 GARRE1 DCAF7 | 3.34e-06 | 1116 | 142 | 17 | 31753913 | |
| Pubmed | Gene structure and evolution of testicular haploid germ cell-specific genes, Oxct2a and Oxct2b. | 5.50e-06 | 9 | 142 | 3 | 15028287 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | GPD2 HBS1L DNAH10 DYNC2H1 PRDX4 NUP88 OAT AHSA1 DIS3 PSMD6 JARID2 FARSA THADA MOGS WDR75 GCLC UCHL1 RPTOR DCAF7 | 5.85e-06 | 1425 | 142 | 19 | 30948266 |
| Pubmed | HBS1L DYNC2H1 ACSS1 BIRC6 SHANK3 ARHGEF15 SLC45A4 THADA SCAP SACS MACF1 | 6.25e-06 | 493 | 142 | 11 | 15368895 | |
| Pubmed | 7.69e-06 | 31 | 142 | 4 | 27798109 | ||
| Pubmed | DYNC2H1 NUP88 OBSL1 AHSA1 DIS3 DCAF5 PSMD6 MOGS MAP1S WDR75 RPTOR DCAF7 | 7.83e-06 | 606 | 142 | 12 | 36538041 | |
| Pubmed | 9.63e-06 | 69 | 142 | 5 | 30352686 | ||
| Pubmed | Ermap, a gene coding for a novel erythroid specific adhesion/receptor membrane protein. | 1.07e-05 | 11 | 142 | 3 | 10721728 | |
| Pubmed | 1.43e-05 | 12 | 142 | 3 | 16765103 | ||
| Pubmed | 1.55e-05 | 76 | 142 | 5 | 27542412 | ||
| Pubmed | NES PRDX4 NUP88 OAT LCP1 TRIP12 BIRC6 DIS3 WDR75 MACF1 MVP SEC23B | 1.64e-05 | 653 | 142 | 12 | 22586326 | |
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 11149928 | ||
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 10477768 | ||
| Pubmed | The tetraspanin CD151 is required for Met-dependent signaling and tumor cell growth. | 1.66e-05 | 2 | 142 | 2 | 20937830 | |
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 9463357 | ||
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 8682296 | ||
| Pubmed | ANK2 autism mutation targeting giant ankyrin-B promotes axon branching and ectopic connectivity. | 1.66e-05 | 2 | 142 | 2 | 31285321 | |
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 22851709 | ||
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 25376607 | ||
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 21277400 | ||
| Pubmed | Comparative analysis of Six 3 and Six 6 distribution in the developing and adult mouse brain. | 1.66e-05 | 2 | 142 | 2 | 15973738 | |
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 39446806 | ||
| Pubmed | Human BMP8A suppresses luteinization of rat granulosa cells via the SMAD1/5/8 pathway. | 1.66e-05 | 2 | 142 | 2 | 31940275 | |
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 9832558 | ||
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 14657231 | ||
| Pubmed | 1.85e-05 | 13 | 142 | 3 | 11456441 | ||
| Pubmed | MAG GPD2 NES ANK2 L1CAM OAT KANK2 SHANK3 PSMD6 FARSA MAP1S SACS HECW2 UCHL1 RPTOR MAST1 PPP1R18 MACF1 | 2.28e-05 | 1431 | 142 | 18 | 37142655 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | HBS1L DCAF6 PRDX4 NUP88 DPP8 ZZEF1 AHSA1 BIRC6 DIS3 PSMD6 FARSA MAP1S GCLC SBDS MACF1 MVP SEC23B MVD | 2.84e-05 | 1455 | 142 | 18 | 22863883 |
| Pubmed | 3.98e-05 | 224 | 142 | 7 | 32941674 | ||
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 9076678 | ||
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 23739867 | ||
| Pubmed | Structural insight into M-band assembly and mechanics from the titin-obscurin-like-1 complex. | 4.95e-05 | 3 | 142 | 2 | 20133654 | |
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 11714688 | ||
| Pubmed | Requirement of Bmp8b for the generation of primordial germ cells in the mouse. | 4.95e-05 | 3 | 142 | 2 | 10894154 | |
| Pubmed | Obscurin targets ankyrin-B and protein phosphatase 2A to the cardiac M-line. | 4.95e-05 | 3 | 142 | 2 | 18782775 | |
| Pubmed | BMP8B increases brown adipose tissue thermogenesis through both central and peripheral actions. | 4.95e-05 | 3 | 142 | 2 | 22579288 | |
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 27496710 | ||
| Pubmed | Mutation in Bmp7 exacerbates the phenotype of Bmp8a mutants in spermatogenesis and epididymis. | 4.95e-05 | 3 | 142 | 2 | 11784057 | |
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 27989621 | ||
| Pubmed | Estrogen mediated epithelial proliferation in the uterus is directed by stromal Fgf10 and Bmp8a. | 4.95e-05 | 3 | 142 | 2 | 25451979 | |
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 34829999 | ||
| Pubmed | Osteogenic activity of the fourteen types of human bone morphogenetic proteins (BMPs). | 4.95e-05 | 3 | 142 | 2 | 12925636 | |
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 12527750 | ||
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 36672824 | ||
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 31098411 | ||
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 10103075 | ||
| Pubmed | Blood pressure influences end-stage renal disease of Cd151 knockout mice. | 4.95e-05 | 3 | 142 | 2 | 22201679 | |
| Pubmed | Molecular basis of the head-to-tail assembly of giant muscle proteins obscurin-like 1 and titin. | 4.95e-05 | 3 | 142 | 2 | 20489725 | |
| Pubmed | 5.73e-05 | 51 | 142 | 4 | 16919471 | ||
| Pubmed | LncRNAs-directed PTEN enzymatic switch governs epithelial-mesenchymal transition. | 6.91e-05 | 168 | 142 | 6 | 30631154 | |
| Pubmed | 8.45e-05 | 341 | 142 | 8 | 29791485 | ||
| Pubmed | 8.89e-05 | 57 | 142 | 4 | 17296600 | ||
| Pubmed | 9.88e-05 | 4 | 142 | 2 | 21501885 | ||
| Pubmed | HAN11 binds mDia1 and controls GLI1 transcriptional activity. | 9.88e-05 | 4 | 142 | 2 | 16887337 | |
| Pubmed | 9.88e-05 | 4 | 142 | 2 | 26147384 | ||
| Pubmed | 9.88e-05 | 4 | 142 | 2 | 16371654 | ||
| Pubmed | Giant ankyrin-B mediates transduction of axon guidance and collateral branch pruning factor sema 3A. | 9.88e-05 | 4 | 142 | 2 | 34812142 | |
| Pubmed | 9.88e-05 | 4 | 142 | 2 | 10473118 | ||
| Pubmed | 9.88e-05 | 4 | 142 | 2 | 37480416 | ||
| Pubmed | Dietary fructose-mediated adipocyte metabolism drives antitumor CD8+ T cell responses. | 9.88e-05 | 4 | 142 | 2 | 37863051 | |
| Pubmed | Whole-exome sequencing points to considerable genetic heterogeneity of cerebral palsy. | 9.88e-05 | 4 | 142 | 2 | 25666757 | |
| Pubmed | 9.88e-05 | 4 | 142 | 2 | 11283023 | ||
| Pubmed | 9.88e-05 | 4 | 142 | 2 | 9434160 | ||
| Pubmed | 9.88e-05 | 4 | 142 | 2 | 8843393 | ||
| Pubmed | BAI1 Suppresses Medulloblastoma Formation by Protecting p53 from Mdm2-Mediated Degradation. | 9.88e-05 | 4 | 142 | 2 | 29894688 | |
| Pubmed | 9.88e-05 | 4 | 142 | 2 | 39025297 | ||
| Pubmed | 9.88e-05 | 4 | 142 | 2 | 9362466 | ||
| Pubmed | 9.88e-05 | 4 | 142 | 2 | 30530672 | ||
| Pubmed | Myelination triggers local loss of axonal CNR/protocadherin alpha family protein expression. | 9.88e-05 | 4 | 142 | 2 | 15579137 | |
| Pubmed | HAPSTR1 localizes HUWE1 to the nucleus to limit stress signaling pathways. | 1.26e-04 | 571 | 142 | 10 | 37167062 | |
| Pubmed | 1.43e-04 | 25 | 142 | 3 | 35478964 | ||
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | GPD2 NES PRDX4 FNBP4 TRIP12 THOC6 FARSA WIZ MOGS SACS SMARCD1 MACF1 MVP SEC23B | 1.46e-04 | 1082 | 142 | 14 | 38697112 |
| Pubmed | 1.64e-04 | 5 | 142 | 2 | 15647482 | ||
| Pubmed | 1.64e-04 | 5 | 142 | 2 | 26034287 | ||
| Pubmed | 1.64e-04 | 5 | 142 | 2 | 10653359 | ||
| Pubmed | 1.64e-04 | 5 | 142 | 2 | 19146846 | ||
| Pubmed | SARA regulates neuronal migration during neocortical development through L1 trafficking. | 1.64e-04 | 5 | 142 | 2 | 27471254 | |
| Pubmed | 1.64e-04 | 5 | 142 | 2 | 32726619 | ||
| Pubmed | Tumor cell integrin β4 and tumor stroma E-/P-selectin cooperatively regulate tumor growth in vivo. | 1.64e-04 | 5 | 142 | 2 | 36932441 | |
| Pubmed | Genomic code for Sox2 binding uncovers its regulatory role in Six3 activation in the forebrain. | 1.64e-04 | 5 | 142 | 2 | 23792023 | |
| Pubmed | Expression of sonic hedgehog, patched, and Gli1 in developing taste papillae of the mouse. | 1.64e-04 | 5 | 142 | 2 | 10096602 | |
| Pubmed | 1.64e-04 | 5 | 142 | 2 | 24823376 | ||
| Pubmed | The Hlx homeobox transcription factor is required early in enteric nervous system development. | 1.64e-04 | 5 | 142 | 2 | 16854219 | |
| Pubmed | 1.75e-04 | 284 | 142 | 7 | 15057824 | ||
| Pubmed | Dachshund homologues play a conserved role in islet cell development. | 1.81e-04 | 27 | 142 | 3 | 20869363 | |
| Pubmed | 2.09e-04 | 608 | 142 | 10 | 16713569 | ||
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | ADGRB1 OBSCN ZZEF1 TRIP12 BIRC6 LOXHD1 WIZ MOGS HECW2 PKD1 SPDYE16 | 2.30e-04 | 736 | 142 | 11 | 29676528 |
| Pubmed | 2.46e-04 | 6 | 142 | 2 | 12149647 | ||
| Pubmed | Essential role of alpha 6 integrins in cortical and retinal lamination. | 2.46e-04 | 6 | 142 | 2 | 9742403 | |
| Pubmed | 2.46e-04 | 6 | 142 | 2 | 12558975 | ||
| Pubmed | 2.46e-04 | 6 | 142 | 2 | 10551828 | ||
| Pubmed | Mouse Dach2 mutants do not exhibit gross defects in eye development or brain function. | 2.46e-04 | 6 | 142 | 2 | 16470613 | |
| Pubmed | 2.46e-04 | 6 | 142 | 2 | 12050133 | ||
| Interaction | NRCAM interactions | 8.60e-06 | 41 | 138 | 5 | int:NRCAM | |
| Interaction | POGLUT1 interactions | 1.21e-05 | 112 | 138 | 7 | int:POGLUT1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19p13 | 2.00e-04 | 797 | 142 | 10 | chr19p13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1p34 | 3.24e-04 | 294 | 142 | 6 | chr1p34 | |
| GeneFamily | EF-hand domain containing | 9.62e-06 | 219 | 86 | 8 | 863 | |
| GeneFamily | WD repeat domain containing | 3.50e-05 | 262 | 86 | 8 | 362 | |
| GeneFamily | WD repeat domain containing|DDB1 and CUL4 associated factors | 8.05e-05 | 18 | 86 | 3 | 498 | |
| GeneFamily | SINE class homeoboxes | 3.31e-04 | 6 | 86 | 2 | 525 | |
| GeneFamily | Bone morphogenetic proteins|Astacins | 1.20e-03 | 11 | 86 | 2 | 455 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 2.26e-03 | 15 | 86 | 2 | 529 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 3.26e-03 | 18 | 86 | 2 | 91 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 3.83e-03 | 66 | 86 | 3 | 722 | |
| GeneFamily | Acyl-CoA synthetase family | 6.75e-03 | 26 | 86 | 2 | 40 | |
| GeneFamily | Fibronectin type III domain containing | 7.15e-03 | 160 | 86 | 4 | 555 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 7.31e-03 | 161 | 86 | 4 | 593 | |
| ToppCell | 5'-Adult-LargeIntestine-Endothelial-blood_vessel_EC-arterial_capillary|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.26e-07 | 197 | 141 | 8 | c29ed0e706999d4c2b93e6e3bf46c42aeceb4813 | |
| ToppCell | Bronchial-10x5prime-Stromal-Schwann|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 8.69e-07 | 162 | 141 | 7 | afffecc6c504930554aafc12c5bffa53e3c5b016 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Endothelial-blood_vessel_EC-Fetal_arterial_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.43e-06 | 189 | 141 | 7 | db09d591b885ce2bc9e353f08b6694e2192582e1 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c05-ZNF683|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.89e-06 | 194 | 141 | 7 | 24837a27b0041fe8c348225fa8b09b127d743603 | |
| ToppCell | 368C-Endothelial_cells-Endothelial-A_(Artery)|368C / Donor, Lineage, Cell class and subclass (all cells) | 3.19e-06 | 197 | 141 | 7 | 7caa2c86dc4d50b57a7db8f7278d1588282ad6db | |
| ToppCell | 368C-Endothelial_cells-Endothelial-A_(Artery)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 3.19e-06 | 197 | 141 | 7 | 951f18f326967206adbbfc422cce9eea3d2e0854 | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | 3.30e-06 | 198 | 141 | 7 | 0c4d2c68a42f8a9e964e2dd28092fe75f5216834 | |
| ToppCell | lymphoid-T_cell-pro-T_cell|World / Lineage, cell class and subclass | 5.60e-06 | 80 | 141 | 5 | 9bd3ad5029eb84efcdbf08fe268c29fa9b0b302b | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_mature_gamma-delta_T_cell-T_gdT_c14-TRDV2|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.40e-06 | 150 | 141 | 6 | 6785b695a01de47a47f5c94fdc432428ef80bada | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_mature_gamma-delta_T_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.40e-06 | 150 | 141 | 6 | ddfb7dd696f06e834c45d6c3f9b1138bc17d62b3 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-CD8-positive,_mature_gamma-delta_T_cell-T_gdT_c14-TRDV2|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.73e-06 | 151 | 141 | 6 | 29d91a7d1470121af45fb8bb35175f2acced4551 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-CD8-positive,_mature_gamma-delta_T_cell|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.73e-06 | 151 | 141 | 6 | 9ebfbdccc9656fce8990d06622f225009633f07c | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-T_cells-MAIT_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.50e-05 | 166 | 141 | 6 | e4f14b2dd8c6199fa27cc3e3beeda681a3b5b889 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells-NK_cells_L.1.3.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.66e-05 | 169 | 141 | 6 | a3234904d7ff8f451ca894e93badd61d75e3cd2a | |
| ToppCell | E16.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.71e-05 | 170 | 141 | 6 | 55fe16d98ea284d05fb899888e4569c685644c7b | |
| ToppCell | mild-Others-CD34+_GATA2+_cells|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.83e-05 | 172 | 141 | 6 | 379f6f271e653d5e404851e51a189bd582bb0f43 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Macroglial-Oligodendrocyte_progenitor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.89e-05 | 173 | 141 | 6 | 2b448acd5e584f24567204c31b8d74715e92f32a | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Macroglial-oligodendrocyte_precursor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.89e-05 | 173 | 141 | 6 | 5086edc29c5a6137ca09877929a1317f9739c801 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c08-IL2RB|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.29e-05 | 179 | 141 | 6 | db76edd368eeca05a2a5d407c3eb2f535ade0ce3 | |
| ToppCell | ASK428-Immune-NK_cell|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.36e-05 | 180 | 141 | 6 | 857d09446e3e6737e83d0f10bfda2ba282d5ba75 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Endothelial-blood_vessel_EC-venous_capillary|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.36e-05 | 180 | 141 | 6 | 97e0dcb7cfbba60a782824c5e23995058609fcd4 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.67e-05 | 184 | 141 | 6 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.67e-05 | 184 | 141 | 6 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.67e-05 | 184 | 141 | 6 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | normal-na-Lymphocytic_NK-NK_dim-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 2.76e-05 | 185 | 141 | 6 | b1a8a8c4d0fc7605eabc17dcb6bd9e8ab4fd578c | |
| ToppCell | 356C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.84e-05 | 186 | 141 | 6 | f0b78c7ee20279970ea8961bf59acb5262f2dce5 | |
| ToppCell | 356C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.84e-05 | 186 | 141 | 6 | 2b3c814a7dee8286ea113c63dc3de5daf0257d37 | |
| ToppCell | wk_15-18-Endothelial-Blood_vessel_endothelial-GRIA2+_arterial_endo|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 3.02e-05 | 188 | 141 | 6 | 366a2d59b9c81d8a7659749f9c07efa46b49a39a | |
| ToppCell | Endothelial-A-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 3.02e-05 | 188 | 141 | 6 | 0824d567356d360fd8e78e840c30529c139f98a1 | |
| ToppCell | droplet-Kidney-nan-21m-Endothelial-kidney_cortex_artery_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.11e-05 | 189 | 141 | 6 | 2ce330d8078833c05775c481e73770f9ee4a5c88 | |
| ToppCell | droplet-Kidney-nan-21m-Endothelial-Pecam____Kidney_cortex_artery_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.11e-05 | 189 | 141 | 6 | 473c87036e04a058b4a5138438b7ba7e1e766799 | |
| ToppCell | human_hepatoblastoma-Endothelial_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 3.20e-05 | 190 | 141 | 6 | 8d6ef93d69e96cd6921816d152bea3b0710cf147 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.30e-05 | 191 | 141 | 6 | 6e1d00404d795ec7cf60f685e42e4ad9a16ac596 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.30e-05 | 191 | 141 | 6 | f158e393976b685b896a41871bda1ab65a8b58f5 | |
| ToppCell | human_hepatoblastoma-Endothelial_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 3.39e-05 | 192 | 141 | 6 | e09f609fed033a25baacaf4a07bbbae1076da366 | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_capillary|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.49e-05 | 193 | 141 | 6 | f582e939e3e08a8a3f71deec78c33715be8faa51 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c08-IL2RB|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.49e-05 | 193 | 141 | 6 | b53ffef20f918b7d1e9d3924562691d13245e2dd | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-T_lymphocytic-CD8-positive,_alpha-beta_T_cell|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.49e-05 | 193 | 141 | 6 | a594f89a18273797506287d9e22f72abe53e4920 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c07-TYROBP|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.60e-05 | 194 | 141 | 6 | 52e09b14159b609af00264a8f38accf37ba8f464 | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_NK-natural_killer_cell-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.70e-05 | 195 | 141 | 6 | 72f42f0be53a2a61f61647118b4883e752d998a5 | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_NK-natural_killer_cell|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.70e-05 | 195 | 141 | 6 | 49a4f58aac168fc1838bd5d2b202135cd794c28b | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_NK|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.70e-05 | 195 | 141 | 6 | acc603dc94ac6518adb0dffb43305b380ec75b52 | |
| ToppCell | 15-Trachea-Epithelial-Epithelial|Trachea / Age, Tissue, Lineage and Cell class | 3.70e-05 | 195 | 141 | 6 | 9e9283a397f56732a0a5f2e2527f154d4c2dd56a | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Endothelial-blood_vessel_EC-Fetal_arterial_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.81e-05 | 196 | 141 | 6 | ae46d4b00be92e64e46252dcc156161b171eded4 | |
| ToppCell | wk_15-18-Hematologic-Myeloid-Neutrophil|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 3.81e-05 | 196 | 141 | 6 | 36c01e0feea33448222010c21442b9fac671bd7d | |
| ToppCell | normal-na-Lymphocytic_NK-NK_dim-female|normal / PBMC cell types (v2) per disease, treatment status, and sex | 3.81e-05 | 196 | 141 | 6 | 61bc0d161e01f36e5bcda4d4f4693afbfe5654bb | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia_independent-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.81e-05 | 196 | 141 | 6 | b8b9801181d7604871b48aebacb295d0a57a5eaf | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_NK-NK_dim-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.81e-05 | 196 | 141 | 6 | c25f90c4e5abfe7cfaa85bfe136c438a5179c978 | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_NK-NK_dim|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.81e-05 | 196 | 141 | 6 | d451f279f4086fcf727af712f98923551181c76e | |
| ToppCell | normal-na-Lymphocytic_NK-NK_dim|normal / PBMC cell types (v2) per disease, treatment status, and sex | 3.81e-05 | 196 | 141 | 6 | 3360d96dc06241498995bcb875615bd4c1424f5a | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_NK-NK_dim-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.92e-05 | 197 | 141 | 6 | 76304df40f87224f8e415677e3ee8fb183fe0c03 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.92e-05 | 197 | 141 | 6 | cd509e49bbdbf991cc5913960ff3ef275ad40628 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.92e-05 | 197 | 141 | 6 | 412cb5f37df57121ddd1492021445479c7cbccbf | |
| ToppCell | (6)_Endothelial_cells|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 4.03e-05 | 198 | 141 | 6 | f38f49d532fa6211f57e36ee494478bdd3f4f89c | |
| ToppCell | (6)_Endothelial-A_(Artery)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 4.03e-05 | 198 | 141 | 6 | 44f8cd5afa3685dcc8bfea0b15af5e8817e12e2e | |
| ToppCell | 368C-Endothelial_cells|368C / Donor, Lineage, Cell class and subclass (all cells) | 4.03e-05 | 198 | 141 | 6 | 9a2c2201baee51581733e183065298a97eba4553 | |
| ToppCell | mild-Plasmablast|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.03e-05 | 198 | 141 | 6 | b14b9e67815f93fac7bd8e5e6f1aa100951b4ac1 | |
| ToppCell | Tracheal-10x3prime_v2-Endothelial-Endothelia_vascular-VE_systemic_venous|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 4.14e-05 | 199 | 141 | 6 | d359f3e1595ba8d8a3dc9eb2e8f2b61f3247c7a1 | |
| ToppCell | Tracheal-10x3prime_v2-Immune_Myeloid-Macrophage_alveolar-Macro_alveolar|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 4.14e-05 | 199 | 141 | 6 | 7648860058eec66019b574ad840d6f5cfa4476d9 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.14e-05 | 199 | 141 | 6 | f35e9c05d0a0339ff691b38564da7aad8e9218aa | |
| ToppCell | proximal-3-Hematologic|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.14e-05 | 199 | 141 | 6 | dff0ca657bfb42083000e3d0125b54480b034a93 | |
| ToppCell | Control-NK|Control / Disease condition and Cell class | 4.14e-05 | 199 | 141 | 6 | f3316fb97c6065286ffd22a0ad9fe7aa5b3b5650 | |
| ToppCell | Tracheal-10x3prime_v2-Immune_Myeloid-Macrophage_alveolar|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 4.14e-05 | 199 | 141 | 6 | 91c72e06a7416671977430211c57938e39e8195e | |
| ToppCell | proximal-Hematologic|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.14e-05 | 199 | 141 | 6 | 183e388ac837585c50fed1189496167c9e61511e | |
| ToppCell | 5'-Adult-LargeIntestine-Endothelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.14e-05 | 199 | 141 | 6 | ffebd99d55d31cf51b4878b2690ed0b9b3799223 | |
| ToppCell | 5'-Adult-LargeIntestine-Endothelial-blood_vessel_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.14e-05 | 199 | 141 | 6 | 258d59cf811bf1668ffbb5f18f961021f660de62 | |
| ToppCell | Parenchyma_COVID-19-Endothelial-TX-Capillary|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 4.26e-05 | 200 | 141 | 6 | 6c0498a5868891e8e22c03469d00669b20249b1a | |
| ToppCell | Lung_Parenchyma-Control-Endothelial-Endothelial-Artery-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.26e-05 | 200 | 141 | 6 | 622206c33640cb2694fe158e8dc55515bb7bd4f5 | |
| ToppCell | Parenchyma_COVID-19-Endothelial-TX-Artery|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 4.26e-05 | 200 | 141 | 6 | 34b279804475ea58fbb052b96f44128c082627a9 | |
| ToppCell | Biopsy_Other_PF-Endothelial|Biopsy_Other_PF / Sample group, Lineage and Cell type | 4.26e-05 | 200 | 141 | 6 | f9916134486fb1dac55f5e7e8deb35e7a3b85770 | |
| ToppCell | Bronchial-10x5prime-Stromal-Pericyte-Muscle_pericyte_pulmonary|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.26e-05 | 200 | 141 | 6 | 12326cc6f0af24bacba9493dc79e7c7347db2f41 | |
| ToppCell | Lung_Parenchyma-Control-Endothelial-Endothelial-Artery|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.26e-05 | 200 | 141 | 6 | 5b4a54cd81bc4d9f5e92798362239e1aa1b70bee | |
| ToppCell | Lung_Parenchyma-Severe-Endothelial-Endothelial-Artery|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.26e-05 | 200 | 141 | 6 | 8552cc7a439449b30b59760c3e8667217b9852b5 | |
| ToppCell | Tracheal-10x5prime-Endothelial-Endothelia_vascular-VE_systemic_arterial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.26e-05 | 200 | 141 | 6 | 5ec31c1be6bcc4124e1489d136570f3de33cc2e9 | |
| ToppCell | Parenchyma_COVID-19-Endothelial-TX|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 4.26e-05 | 200 | 141 | 6 | abcbd5a156aa4fd51d284441388975c81c0b88ae | |
| ToppCell | Biopsy_IPF-Endothelial-Endothelial_cells|Biopsy_IPF / Sample group, Lineage and Cell type | 4.26e-05 | 200 | 141 | 6 | 39b4faad5700b3108f851f0df7fea3d298514465 | |
| ToppCell | Tracheal-10x3prime_v2-Endothelial|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 4.26e-05 | 200 | 141 | 6 | 2e51195810bca8a98488a8a06c538feaa27f1f28 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_hypoxia/MES-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.26e-05 | 200 | 141 | 6 | 5f1de1f9305e1784c12d526f6c8bdd7d56229f9b | |
| ToppCell | Lung_Parenchyma-Severe-Endothelial-Endothelial-Capillary-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.26e-05 | 200 | 141 | 6 | 7020045b933cb104fb99b79524cb0d4734b8636d | |
| ToppCell | Biopsy_Other_PF-Endothelial-Endothelial_cells|Biopsy_Other_PF / Sample group, Lineage and Cell type | 4.26e-05 | 200 | 141 | 6 | 40d57a383c79d3365e033d08efd9371f0bc5bf55 | |
| ToppCell | Lung_Parenchyma-Severe-Endothelial|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.26e-05 | 200 | 141 | 6 | d9d0ffa18e5b4647966e19ad9830cbba6120677e | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.26e-05 | 200 | 141 | 6 | 2e47888e041ec3d265425d1df97b6665c6da889c | |
| ToppCell | Bronchial-10x5prime-Endothelial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.26e-05 | 200 | 141 | 6 | ad34c978cc6b89b4c1c8c9b2fb2a938051b555a0 | |
| ToppCell | Lung_Parenchyma-Severe-Endothelial-Endothelial-Capillary|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.26e-05 | 200 | 141 | 6 | e9913511a129bb3cee85e7ebf565b951dab91542 | |
| ToppCell | Lung_Parenchyma-Severe-Endothelial-Endothelial|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.26e-05 | 200 | 141 | 6 | e9d5ba140cabae11c437012d519b85f5412dcc94 | |
| ToppCell | Parenchyma_Control_(B.)-Endothelial-TX-Artery|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 4.26e-05 | 200 | 141 | 6 | 590d1c0f86f136c7e76ea107fbb8ac5ff1164386 | |
| ToppCell | Bronchial-10x5prime-Stromal-Pericyte|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.26e-05 | 200 | 141 | 6 | 362706445edb33b313684efe50b1f44f5f816e67 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.26e-05 | 200 | 141 | 6 | 50fa0f8a3e490d5941b34e66a10158eba6c909d4 | |
| ToppCell | Biopsy_IPF-Endothelial|Biopsy_IPF / Sample group, Lineage and Cell type | 4.26e-05 | 200 | 141 | 6 | 7ccd3b617838b39da814278dc0e12384013401ce | |
| ToppCell | Lung_Parenchyma-Severe-Endothelial-Endothelial-Artery-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.26e-05 | 200 | 141 | 6 | 45c08f1befe78553bbadcc2fcffb6138306638f3 | |
| ToppCell | Globus_pallidus-Macroglia-POLYDENDROCYTE-P1|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 7.55e-05 | 137 | 141 | 5 | 80f1a6cfb48ccfba1c3545fdcd5fcb3157272aca | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c06-TNF|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.12e-04 | 149 | 141 | 5 | 3378d0fe79de6d7879fd48717ded5027593c785f | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c11-GNLY|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.12e-04 | 149 | 141 | 5 | 1328ce0104d40215ee68abfdbf74eb47b87a7b5b | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Myeloid-neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.48e-04 | 158 | 141 | 5 | d43b335e6aa12d84a75b988fbd6127ff1f4af25c | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Myeloid-Neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.48e-04 | 158 | 141 | 5 | ab12b29ce51ca2fcac469cc932391217d97145f9 | |
| ToppCell | LPS-antiTNF-Myeloid-Monocytes,_Macrophages-Neutrophils|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.56e-04 | 160 | 141 | 5 | 5d8d97c3da5837ba5fe743d2f8438f5cb7cea64b | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.56e-04 | 160 | 141 | 5 | a494001b1f6dec33624f98fa3c24bad6988d0425 | |
| ToppCell | ICU-NoSEP-Lymphocyte-T_NK-gdT|ICU-NoSEP / Disease, Lineage and Cell Type | 1.56e-04 | 160 | 141 | 5 | 2798c5bd971407f27dd4d3a4831d63d9c88003c3 | |
| ToppCell | VE-mono3|VE / Condition, Cell_class and T cell subcluster | 1.61e-04 | 161 | 141 | 5 | 7df3fefc55ab43b897fc78d1f0c7383b10ac33d5 | |
| ToppCell | facs-Pancreas-Exocrine-18m-Hematologic-nan|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.61e-04 | 161 | 141 | 5 | 16f77e7a5444d2f2b210362816cd7a07b9b42af6 | |
| Disease | behavior | 1.23e-04 | 55 | 136 | 4 | GO_0007610 | |
| Disease | Aplastic anemia | 2.09e-04 | 5 | 136 | 2 | cv:C0002874 | |
| Disease | Aplastic anemia, idiopathic | 2.09e-04 | 5 | 136 | 2 | C0348890 | |
| Disease | APLASTIC ANEMIA | 2.09e-04 | 5 | 136 | 2 | 609135 | |
| Disease | aspartate aminotransferase measurement, serum alanine aminotransferase measurement, low density lipoprotein triglyceride measurement, body fat percentage, high density lipoprotein cholesterol measurement, sex hormone-binding globulin measurement | 2.97e-04 | 364 | 136 | 8 | EFO_0004612, EFO_0004696, EFO_0004735, EFO_0004736, EFO_0007800, EFO_0009946 | |
| Disease | reticulocyte count | PITHD1 HBS1L DNAH10 LCP1 KANK2 BIRC6 SLC45A4 NCR3 THADA PKD1 PALM3 MAST1 ADAM33 HOMEZ | 3.46e-04 | 1045 | 136 | 14 | EFO_0007986 |
| Disease | Aplastic Anemia | 4.36e-04 | 7 | 136 | 2 | C0002874 | |
| Disease | Hypoplastic anemia | 4.36e-04 | 7 | 136 | 2 | C0178416 | |
| Disease | holoprosencephaly (is_implicated_in) | 5.80e-04 | 8 | 136 | 2 | DOID:4621 (is_implicated_in) | |
| Disease | Holoprosencephaly sequence | 9.26e-04 | 10 | 136 | 2 | cv:C0079541 | |
| Disease | obsolete_red blood cell distribution width | MAG HBS1L IRF2BP1 SLC27A6 LCP1 KANK2 BIRC6 CILP2 LOXHD1 HECW2 MAST1 PLAUR BMP8A GARRE1 SEC23B | 1.41e-03 | 1347 | 136 | 15 | EFO_0005192 |
| Disease | aplastic anemia (is_implicated_in) | 1.59e-03 | 13 | 136 | 2 | DOID:12449 (is_implicated_in) | |
| Disease | visceral adipose tissue measurement | 1.80e-03 | 481 | 136 | 8 | EFO_0004765 | |
| Disease | Tobacco Dependence | 1.85e-03 | 14 | 136 | 2 | C0040332 | |
| Disease | benign prostatic hyperplasia | 1.85e-03 | 14 | 136 | 2 | EFO_0000284 | |
| Disease | Nicotine Dependence | 1.85e-03 | 14 | 136 | 2 | C0028043 | |
| Disease | Nicotine Use Disorder | 1.85e-03 | 14 | 136 | 2 | C0376384 | |
| Disease | body fat percentage | 1.97e-03 | 488 | 136 | 8 | EFO_0007800 | |
| Disease | Alobar Holoprosencephaly | 2.13e-03 | 15 | 136 | 2 | C0431363 | |
| Disease | testosterone measurement | ZNF219 ANK2 IRF2BP1 SLC27A6 FNBP4 BIRC6 ARHGEF15 THADA TXNDC15 ZFHX4 PALM3 MACF1 BMP8A INS-IGF2 | 2.32e-03 | 1275 | 136 | 14 | EFO_0004908 |
| Disease | very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 2.36e-03 | 291 | 136 | 6 | EFO_0008317, EFO_0020946 | |
| Disease | Lobar Holoprosencephaly | 2.43e-03 | 16 | 136 | 2 | C0431362 | |
| Disease | Semilobar Holoprosencephaly | 2.43e-03 | 16 | 136 | 2 | C0751617 | |
| Disease | Holoprosencephaly | 2.74e-03 | 17 | 136 | 2 | C0079541 | |
| Disease | obesity (implicated_via_orthology) | 3.26e-03 | 215 | 136 | 5 | DOID:9970 (implicated_via_orthology) | |
| Disease | esterified cholesterol measurement, high density lipoprotein cholesterol measurement | 3.43e-03 | 19 | 136 | 2 | EFO_0004612, EFO_0008589 | |
| Disease | aggressive behaviour measurement, ADHD symptom measurement | 3.86e-03 | 68 | 136 | 3 | EFO_0007826, EFO_0007860 | |
| Disease | Anophthalmia-microphthalmia syndrome | 4.18e-03 | 21 | 136 | 2 | cv:C5680330 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VALIWERDEPGTEVR | 126 | Q9NUB1 | |
| QVAELWGRGDRIESL | 251 | Q99944 | |
| WGRGDRIESLSDQVL | 256 | Q99944 | |
| SIDIWTLGEEVDGRR | 1816 | Q9NR09 | |
| VRSGEWTEDEVLRRF | 216 | Q13938 | |
| ESELIEQGRVVLWGR | 66 | A8MYA2 | |
| EGDPRWIVEERADAT | 6 | O95433 | |
| LELRSVEWERSGATI | 1556 | O14514 | |
| REVARDWLRVGSVLD | 436 | P46098 | |
| ALTGLEVWTERDRSR | 256 | Q9BZ11 | |
| VRRWLSSVEEAVGDR | 636 | Q9BSW2 | |
| WSRRLEFQGELTELG | 631 | O94989 | |
| GEDGTVRWFDTRIKT | 161 | Q58WW2 | |
| EETWITCEDRIRVRG | 1236 | Q9NR16 | |
| FENREGEWEGRVSEL | 156 | Q6ZP65 | |
| LEGSLRGELESRWEK | 271 | A6NI56 | |
| RVWRVGETETRLECL | 96 | P61962 | |
| GILEWEDREQGIFRV | 191 | Q9UKW6 | |
| KWIDDVRTEGGSDVI | 106 | Q53S08 | |
| IVREVEGDLGTLQWT | 36 | Q4KMZ1 | |
| RVGREDEDGWETRGD | 11 | Q96HZ4 | |
| WVLDETGEERERGVT | 311 | Q9Y450 | |
| GVVSVVWEGLRATED | 216 | A6NDB9 | |
| SRSERGLVEEEWVIV | 1581 | Q01484 | |
| EELGEVWQRRGSLEG | 731 | Q9P2P5 | |
| ETLEAGVEGRWSRDG | 451 | O75147 | |
| QLFTTELGRDGIRWE | 291 | P0C5J1 | |
| ARWRLTEEDGQLGIA | 1916 | Q14667 | |
| DVEVRRGDVLAAWSG | 386 | P43304 | |
| ELERGIRSWDVDPGV | 36 | Q66K74 | |
| EEVIWDVLSGIGVRA | 1016 | O60732 | |
| LGRLREDEGTWVQVS | 186 | P20916 | |
| GRLAIGSVTWFRDEV | 46 | O14931 | |
| GAVEETAWKTERLGR | 21 | Q96MC5 | |
| GGETRENVWLILEGR | 1821 | Q8IVV2 | |
| DWGALEGETREERTF | 386 | P13796 | |
| AWLAGEGVDVTSLRR | 41 | P14222 | |
| RWGVISASVDDRTRE | 296 | P48506 | |
| SSDDGRVLIWDIRES | 161 | Q96JK2 | |
| EELARRLGEAWRGAV | 176 | P48681 | |
| GTIRSDLEELWELRG | 46 | Q96LW2 | |
| TEDRIWLNGREEDVG | 61 | P53602 | |
| GIEAVRWLLEERGTL | 86 | Q96LR2 | |
| VARLESWEVRDGGLG | 96 | Q7L591 | |
| ITWRGDGRDLQELGD | 551 | P32004 | |
| TWATTRLELEGRGVV | 411 | Q7L4E1 | |
| LDEDRGRVCVSVEWG | 261 | P52790 | |
| EGWGREREGVITIES | 1606 | P16144 | |
| GELWSILRDRGSFDE | 536 | Q13237 | |
| DGKERVTGEEWLVTT | 186 | Q14764 | |
| LRLRDTESGWDDTAV | 456 | Q8ND30 | |
| GRERWVLEVVEERTT | 1476 | Q9Y2H9 | |
| GWLREVEEELATSGG | 5576 | Q9UPN3 | |
| DGWIGREQILGDEAR | 481 | Q13724 | |
| REEAERGVLWIGPDT | 5406 | Q5VST9 | |
| AGREDELTITEGEWL | 481 | Q86WN1 | |
| REALRELDLWGVGAV | 1261 | Q8NCM8 | |
| WRQLRDGFTSEGEIL | 166 | A6NGN9 | |
| ERWLGTRGDPAREEV | 96 | Q5SZD1 | |
| TELRNREVFGWTGEL | 346 | A8K855 | |
| EIAITSGEWEVLGRH | 511 | Q6V1X1 | |
| PEVEEAVRSWRGAAE | 221 | O15063 | |
| AEWGRRERLETEKLG | 356 | Q96A19 | |
| TLRAGDEGWLVLDVT | 186 | Q7Z5Y6 | |
| WDVIGRSLIIDEGED | 191 | O14618 | |
| LSRGWSEEELQGVLR | 376 | Q9H4A9 | |
| ALETRSVGTWVRERD | 261 | Q63ZY3 | |
| GLVLLRDSVEWEGRS | 26 | Q8TE02 | |
| EIGWDSEALVDPERR | 91 | Q6ZVS7 | |
| GISWSSEEIEETRAR | 111 | Q8IX15 | |
| DSEWIRSQEAGGRVV | 166 | P48509 | |
| TLRAGDEGWLVLDVT | 186 | P34820 | |
| IRGSILEAREFDWES | 1756 | Q8IVF4 | |
| SEEEEEGAVRWGRQA | 356 | Q9NYF3 | |
| LEATEWRLRSGEERQ | 256 | Q6NYC8 | |
| ITEDGRTVAVGDIVW | 481 | Q6NUJ5 | |
| EGESVITWDFDILRG | 531 | O43304 | |
| VVGRSSGRLEVWDAI | 981 | Q12770 | |
| VVGWRSGVEKDLDEV | 36 | Q9Y3A5 | |
| VSEQRLWRGGRELSD | 46 | Q9NZJ4 | |
| EWRQLGELLTDGVRS | 326 | Q8IU81 | |
| RGRRVTTELVWEEVD | 136 | F8WCM5 | |
| VTRAEVEARLGAWAG | 551 | Q8WZA9 | |
| SLIEEGGDWDRRNRL | 166 | Q15008 | |
| RVWSDTRDLVLDGSE | 2266 | P98161 | |
| DDSDGIPWSEERVVR | 16 | Q92833 | |
| DIRGWDVETGRSVAS | 186 | Q96AX9 | |
| WDGEDSSFLVVRLRG | 71 | Q99567 | |
| VGSWFGAREETIRRE | 811 | Q5JY77 | |
| LRVITTVDEDWLRCG | 871 | Q9BVN2 | |
| FGRWIADGQRELIES | 171 | Q7Z4G4 | |
| LESLGFWEEVRGIIS | 1481 | Q6YHU6 | |
| FWEEVRGIISGSELI | 1486 | Q6YHU6 | |
| EAERWGVALREVIAS | 186 | Q7Z736 | |
| QGWETEERPRTREEE | 36 | Q13162 | |
| EGTVASWELRVEGRL | 201 | Q96GM5 | |
| SWELRVEGRLLEDSA | 206 | Q96GM5 | |
| WELTAEGEEIAREGS | 61 | Q9Y285 | |
| GEEGKREAEAWTRRA | 56 | Q5TG53 | |
| TETRIADWREGALNG | 561 | Q8N3X1 | |
| TLRGWDSVDREVAEI | 236 | P22732 | |
| EELWVEVGGRVSREL | 126 | Q13635 | |
| ETGDIERLGRFLWSL | 101 | O95343 | |
| LEESGDVERLGRFLW | 21 | O95475 | |
| LQEGEEGIRAWTEGE | 2666 | Q9UKZ4 | |
| QGLGERRRPWSEEEE | 556 | O95785 | |
| RVIGELGEDGWIRVQ | 621 | Q9BVR0 | |
| STLEGRRIIVAIDGW | 391 | Q9Y2L1 | |
| LLALEEERGGWRTAD | 226 | Q92935 | |
| IADEIQTGLARTGRW | 261 | P04181 | |
| SGDVRIVRIWDTDRE | 1141 | Q8N122 | |
| AESEEGPDVLRWLDR | 536 | Q15437 | |
| EVRGSEVLVTFDGWR | 191 | Q96GD3 | |
| GGLDALDVGRWRVSD | 41 | P54922 | |
| EPEDWGILGREEART | 271 | Q0VD83 | |
| PETGLWEEESGFRRE | 686 | Q8IUL8 | |
| EQELREWIEGVTGRR | 31 | P51911 | |
| EEGEGETTVRLLWLS | 486 | Q5BKX6 | |
| IVGWEGLDILDRSSE | 441 | Q96N96 | |
| VLVESSERLGGWIRS | 31 | P50336 | |
| ERSLPEEEWRAVIGD | 901 | Q86UP3 | |
| RGEELWILEEESSGH | 81 | P51786 | |
| CRTTIVRLWEEGEEL | 46 | Q03405 | |
| LHGIDLRWGVTEEET | 936 | Q99973 | |
| ERTLDRRSDGTWGTE | 296 | M0QZC1 | |
| ESVDVEGVAWRAGLR | 611 | Q9BYB0 | |
| RAWGLEVDRVELAVE | 206 | Q9UBI4 | |
| VGDRVIDVGSEWRTF | 41 | Q00403 | |
| GGRESVLVEWRDATE | 266 | Q8IWA0 | |
| GLRGEWTELRRHEVT | 171 | Q9GZP4 | |
| AVGWTVERTKEGEAL | 2681 | Q15413 | |
| LEGWHVEGTDRLRVS | 551 | P35590 | |
| SGRAWVSREELEEIQ | 281 | A6NNV3 | |
| SGRAWVSREELEEIQ | 321 | P0DV79 | |
| DDATELWGIRVARVE | 176 | Q8TAV4 | |
| RGVEVAEESGRLWSE | 31 | Q96J42 | |
| GGEDGAVRLWDLRTA | 186 | Q86W42 | |
| ESDSGVVLRRIWEAE | 56 | Q9UH36 | |
| RVEVSLDGVWGRVLD | 446 | Q4G0T1 | |
| EERGEQWTTDRGVLS | 256 | Q96JL9 | |
| FRWLEERLGRGEESV | 81 | O43149 | |
| IGNGIRSDVWREFLD | 336 | Q9Y2P4 | |
| ELQRADLGLWRGEEV | 1641 | Q14669 | |
| WEAEVGGSLEVRSLR | 26 | Q9P1C3 | |
| TSELERGEGWTAARE | 76 | O95932 | |
| GLRLEREAGEGWASE | 706 | Q63HR2 | |
| EVVEAEEETWARGRS | 431 | Q9P2Y4 | |
| WRFVDVLGLEEESLG | 26 | P09936 | |
| EEAGVREAGLRVTWL | 116 | Q6IQ20 |